Literature DB >> 19582499

PTPN11 gene mutation and severe neonatal hypertrophic cardiomyopathy: what is the link?

Maria Felicia Faienza1, Lucia Giordani, Marina Ferraris, Gianni Bona, Luciano Cavallo.   

Abstract

Noonan syndrome (NS) is an autosomal dominant disorder characterized by multiple dysmorphic features and a broad spectrum of congenital heart defects. Specific mutations of the PTPN11 gene are associated with 50% of the NS cases and 90% of the multiple lentigines/LEOPARD syndrome (ML/LS) cases. These two allelic conditions have several overlapping clinical features. This study describes the association between the Gln510Glu mutation of the PTPN11 gene and lethal progressive hypertrophic cardiomyopathy (HCM) in a newborn with the NS phenotype. The findings confirm the intriguing relationship between site-specific mutations of the PTPN11 gene and rapidly progressive HCM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582499     DOI: 10.1007/s00246-009-9473-7

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  13 in total

1.  Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes.

Authors:  A Sarkozy; E Conti; D Seripa; M C Digilio; N Grifone; C Tandoi; V M Fazio; V Di Ciommo; B Marino; A Pizzuti; B Dallapiccola
Journal:  J Med Genet       Date:  2003-09       Impact factor: 6.318

2.  Genetic heterogeneity in LEOPARD syndrome: two families with no mutations in PTPN11.

Authors:  Kamini Kalidas; Adam C Shaw; Andrew H Crosby; Ruth Newbury-Ecob; Lynn Greenhalgh; Isabel K Temple; Caroline Law; Amisha Patel; Michael A Patton; Steve Jeffery
Journal:  J Hum Genet       Date:  2004-12-10       Impact factor: 3.172

3.  PTPN11 gene mutations: linking the Gln510Glu mutation to the "LEOPARD syndrome phenotype".

Authors:  M Cristina Digilio; Anna Sarkozy; Giuseppe Pacileo; Giuseppe Limongelli; Bruno Marino; Bruno Dallapiccola
Journal:  Eur J Pediatr       Date:  2006-05-30       Impact factor: 3.183

4.  Germline gain-of-function mutations in SOS1 cause Noonan syndrome.

Authors:  Amy E Roberts; Toshiyuki Araki; Kenneth D Swanson; Kate T Montgomery; Taryn A Schiripo; Victoria A Joshi; Li Li; Yosuf Yassin; Alex M Tamburino; Benjamin G Neel; Raju S Kucherlapati
Journal:  Nat Genet       Date:  2006-12-03       Impact factor: 38.330

5.  PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype-phenotype correlation, and phenotypic heterogeneity.

Authors:  Marco Tartaglia; Kamini Kalidas; Adam Shaw; Xiaoling Song; Dan L Musat; Ineke van der Burgt; Han G Brunner; Débora R Bertola; Andrew Crosby; Andra Ion; Raju S Kucherlapati; Steve Jeffery; Michael A Patton; Bruce D Gelb
Journal:  Am J Hum Genet       Date:  2002-05-01       Impact factor: 11.025

6.  Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome.

Authors:  M Tartaglia; E L Mehler; R Goldberg; G Zampino; H G Brunner; H Kremer; I van der Burgt; A H Crosby; A Ion; S Jeffery; K Kalidas; M A Patton; R S Kucherlapati; B D Gelb
Journal:  Nat Genet       Date:  2001-12       Impact factor: 38.330

7.  Grouping of multiple-lentigines/LEOPARD and Noonan syndromes on the PTPN11 gene.

Authors:  Maria Cristina Digilio; Emanuela Conti; Anna Sarkozy; Rita Mingarelli; Tania Dottorini; Bruno Marino; Antonio Pizzuti; Bruno Dallapiccola
Journal:  Am J Hum Genet       Date:  2002-06-07       Impact factor: 11.025

8.  Germline KRAS mutations cause Noonan syndrome.

Authors:  Suzanne Schubbert; Martin Zenker; Sara L Rowe; Silke Böll; Cornelia Klein; Gideon Bollag; Ineke van der Burgt; Luciana Musante; Vera Kalscheuer; Lars-Erik Wehner; Hoa Nguyen; Brian West; Kam Y J Zhang; Erik Sistermans; Anita Rauch; Charlotte M Niemeyer; Kevin Shannon; Christian P Kratz
Journal:  Nat Genet       Date:  2006-02-12       Impact factor: 38.330

9.  Hyperthrophic cardiomyopathy and the PTPN11 gene.

Authors:  Anna Sarkozy; Emanuela Conti; Francesca Romana Lepri; Antonio Pizzuti; Bruno Dallapiccola; Camillo Autore; Marco Tartaglia
Journal:  Am J Med Genet A       Date:  2005-07-01       Impact factor: 2.802

10.  Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.

Authors:  Bhaswati Pandit; Anna Sarkozy; Len A Pennacchio; Claudio Carta; Kimihiko Oishi; Simone Martinelli; Edgar A Pogna; Wendy Schackwitz; Anna Ustaszewska; Andrew Landstrom; J Martijn Bos; Steve R Ommen; Giorgia Esposito; Francesca Lepri; Christian Faul; Peter Mundel; Juan P López Siguero; Romano Tenconi; Angelo Selicorni; Cesare Rossi; Laura Mazzanti; Isabella Torrente; Bruno Marino; Maria C Digilio; Giuseppe Zampino; Michael J Ackerman; Bruno Dallapiccola; Marco Tartaglia; Bruce D Gelb
Journal:  Nat Genet       Date:  2007-07-01       Impact factor: 38.330

View more
  12 in total

1.  Heterozygous deletion of AKT1 rescues cardiac contractility, but not hypertrophy, in a mouse model of Noonan Syndrome with Multiple Lentigines.

Authors:  Rajika Roy; Maike Krenz
Journal:  J Mol Cell Cardiol       Date:  2017-09-11       Impact factor: 5.000

Review 2.  Growth plate gene involment and isolated short stature.

Authors:  Maria Felicia Faienza; Mariangela Chiarito; Giacomina Brunetti; Gabriele D'Amato
Journal:  Endocrine       Date:  2020-06-05       Impact factor: 3.633

3.  Pulmonary interstitial glycogenosis associated with pulmonary hypertension and hypertrophic cardiomyopathy.

Authors:  Abdullah Alkhorayyef; Lindsay Ryerson; Alicia Chan; Ernest Phillipos; Atilano Lacson; Ian Adatia
Journal:  Pediatr Cardiol       Date:  2012-03-28       Impact factor: 1.655

4.  Rapidly progressive hypertrophic cardiomyopathy in an infant with Noonan syndrome with multiple lentigines: palliative treatment with a rapamycin analog.

Authors:  Andreas Hahn; Jessica Lauriol; Josef Thul; Kachina Behnke-Hall; Tushiha Logeswaran; Anne Schänzer; Nuray Böğürcü; Boyan K Garvalov; Martin Zenker; Bruce D Gelb; Susanne von Gerlach; Reinhard Kandolf; Maria I Kontaridis; Dietmar Schranz
Journal:  Am J Med Genet A       Date:  2015-02-23       Impact factor: 2.802

5.  New approaches to prevent LEOPARD syndrome-associated cardiac hypertrophy by specifically targeting Shp2-dependent signaling.

Authors:  Christine Schramm; Michelle A Edwards; Maike Krenz
Journal:  J Biol Chem       Date:  2013-05-14       Impact factor: 5.157

6.  NGS testing for cardiomyopathy: Utility of adding RASopathy-associated genes.

Authors:  Ozge Ceyhan-Birsoy; Maya M Miatkowski; Elizabeth Hynes; Birgit H Funke; Heather Mason-Suares
Journal:  Hum Mutat       Date:  2018-05-16       Impact factor: 4.878

7.  A rasopathy phenotype with severe congenital hypertrophic obstructive cardiomyopathy associated with a PTPN11 mutation and a novel variant in SOS1.

Authors:  Jill A Fahrner; Aisha Frazier; Suha Bachir; Michael F Walsh; Carolyn D Applegate; Reid Thompson; Marc K Halushka; Anne M Murphy; Meral Gunay-Aygun
Journal:  Am J Med Genet A       Date:  2012-05-14       Impact factor: 2.802

8.  LEOPARD syndrome in an infant with severe hypertrophic cardiomyopathy and PTPN11 mutation.

Authors:  Madhusudan Ganigara; Atul Prabhu; Raghvannair Suresh Kumar
Journal:  Ann Pediatr Cardiol       Date:  2011-01

9.  A Novel Noonan Syndrome RAF1 Mutation: Lethal Course in a Preterm Infant.

Authors:  Ana Ratola; Helena Moreira Silva; Ana Guedes; Céu Mota; Ana Cristina Braga; Dulce Oliveira; Artur Alegria; Carmen Carvalho; Sílvia Álvares; Elisa Proença
Journal:  Pediatr Rep       Date:  2015-06-24

10.  Novel missense mutation of SASH1 in a Chinese family with dyschromatosis universalis hereditaria.

Authors:  Lu Cao; Ruixue Zhang; Liang Yong; Shirui Chen; Hui Zhang; Weiwei Chen; Qiongqiong Xu; Huiyao Ge; Yiwen Mao; Qi Zhen; Yafen Yu; Xia Hu; Liangdan Sun
Journal:  BMC Med Genomics       Date:  2021-06-26       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.